Ruxolitinib for Vitiligo Approved for Marketing in EU ...Middle East

Medscape - News
Last year in the United States, the topical JAK inhibitor became the first repigmentation treatment approved by the FDA for nonsegmental vitiligo, the most common form of the disease. Medscape Medical News

Hence then, the article about ruxolitinib for vitiligo approved for marketing in eu was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ruxolitinib for Vitiligo Approved for Marketing in EU )

Apple Storegoogle play

Last updated :

Also on site :